Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Up 143.1% in October

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) saw a large increase in short interest in October. As of October 15th, there was short interest totaling 104,300 shares, an increase of 143.1% from the September 30th total of 42,900 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 137,700 shares, the days-to-cover ratio is currently 0.8 days. Based on an average daily trading volume, of 137,700 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.1% of the company’s stock are sold short.

Institutional Investors Weigh In On Xtant Medical

Hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC acquired a new stake in shares of Xtant Medical in the 2nd quarter valued at $26,000. Mink Brook Asset Management LLC raised its holdings in shares of Xtant Medical by 125.8% in the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock valued at $81,000 after purchasing an additional 60,997 shares in the last quarter. Crescent Grove Advisors LLC raised its holdings in shares of Xtant Medical by 94.3% in the 2nd quarter. Crescent Grove Advisors LLC now owns 412,024 shares of the medical device company’s stock valued at $304,000 after purchasing an additional 200,000 shares in the last quarter. AWM Investment Company Inc. acquired a new stake in shares of Xtant Medical in the 2nd quarter valued at $4,875,000. Finally, Nantahala Capital Management LLC raised its holdings in shares of Xtant Medical by 500.3% in the 2nd quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company’s stock valued at $50,543,000 after purchasing an additional 57,000,000 shares in the last quarter. 69.33% of the stock is currently owned by institutional investors and hedge funds.

Xtant Medical Price Performance

Xtant Medical stock opened at $0.88 on Friday. The firm has a market cap of $123.13 million, a PE ratio of -21.99 and a beta of -0.22. Xtant Medical has a 52-week low of $0.33 and a 52-week high of $0.95. The company has a quick ratio of 1.16, a current ratio of 2.47 and a debt-to-equity ratio of 0.46. The company’s 50 day moving average is $0.69 and its two-hundred day moving average is $0.64.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.